Impact of immunosuppressants on the therapeutic efficacy of in vitro-expanded CD4+CD25+Foxp3+ regulatory T cells in allotransplantation.
Lim
Dong-Gyun
DG
Department of Surgery, Ulsan University College of Medicine and Asan Medical Center, Seoul, Korea. dglim@amc.seoul.kr
Koo
Sun-Kyung
SK
Park
Youn-Hee
YH
Kim
Youngji
Y
Kim
Hye-Mi
HM
Park
Chan-Sik
CS
Kim
Song-Cheol
SC
Han
Duck-Jong
DJ
D019264:Adoptive Transfer; D000818:Animals; D000906:Antibodies / Q000494:pharmacology; D019013:CD40 Antigens / Q000378:metabolism; D023201:CD40 Ligand / Q000276:immunology / Q000378:metabolism; D049109:Cell Proliferation / Q000187:drug effects*; D002478:Cells, Cultured; D016572:Cyclosporine / Q000494:pharmacology; D004195:Disease Models, Animal; D051858:Forkhead Transcription Factors / Q000032:analysis*; D006084:Graft Rejection / Q000276:immunology / Q000517:prevention & control*; D006086:Graft vs Host Disease / Q000276:immunology / Q000517:prevention & control*; D007166:Immunosuppressive Agents / Q000009:adverse effects / Q000494:pharmacology*; D053645:Interleukin-2 Receptor alpha Subunit / Q000032:analysis*; D007519:Isoantigens / Q000276:immunology; D008297:Male; D051379:Mice; D008809:Mice, Inbred C3H; D008810:Mice, Inbred C57BL; D008811:Mice, Inbred DBA; D009173:Mycophenolic Acid / Q000031:analogs & derivatives / Q000494:pharmacology; D020123:Sirolimus / Q000494:pharmacology; D016038:Skin Transplantation / Q000009:adverse effects*; D050378:T-Lymphocytes, Regulatory / Q000187:drug effects* / Q000276:immunology / Q000637:transplantation; D013997:Time Factors; D023001:Transplantation Tolerance / Q000187:drug effects; D014184:Transplantation, Homologous
D000906:Antibodies; D019013:CD40 Antigens; D051858:Forkhead Transcription Factors; C498833:Foxp3 protein, mouse; C508018:Il2ra protein, mouse; D007166:Immunosuppressive Agents; D053645:Interleukin-2 Receptor alpha Subunit; D007519:Isoantigens; D023201:CD40 Ligand; D016572:Cyclosporine; D009173:Mycophenolic Acid; D020123:Sirolimus